Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization

Hepato-Gastroenterology

Volumn 56, Issue 89, 2009, Pages 213-217

  Hiraoka, Atsushi ^a   Horiike, Norio ^a   Yamashita, Yoshimasa ^a   Koizumi, Yohei ^a   Doi, Hirokazu ^a   Yamamoto, Yasunori ^a   Ichikawa, Soichiro ^a   Hasebe, Aki ^a   Yano, Makoto ^a   Miyamoto, Yasunao ^a   Ninomiya, Tomoyuki ^a   Ootani, Hiromi ^a   Takamura, Kazuto ^a   Kawasaki, Hideki ^a   Otomi, Yoichi ^a   Kogame, Masahiro ^a   Sogabe, Ichiro ^a   Ishimaru, Yoshihiro ^a   Kashihara, Kenichi ^a   Miyagawa, Masao ^a   Hirooka, Masashi ^b   Hiasa, Yoichi ^b   Matsuura, Bunzo ^b   Michitaka, Kojiro ^b   Onji, Morikazu ^b   more..

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Prognosis; Scoring system; Transarterial therapy; Transcatheter arterial chemoembolization; Unresectable hepatocellular carcinoma

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; EPIRUBICIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SCORING SYSTEM; TUMOR VOLUME;

AGED; ALBUMINS; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM INVASIVENESS; PORTAL VEIN; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 64949202596     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lladóó L, Virgili J, Figueras J, et al: A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Cancer 2000; 88:50-57.
2. Lo CM, Ngan H, Tso WK, et al: Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002; 35:1164-1171.
3. Llovet JM, Real MI, Montañá X, et al: Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 2002; 359:1734-1739.
4. Cammá C, Schepis F, Orlando A, et al: Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224:47-54.
5. Arii B, Yamamoto Y, Futagawa S, et al: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology 2000; 32:1224-1229.
6. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985; 56:918-928.
7. The Cancer of the Liver Italian Program (CLIP) investigators. A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients. Hepatology 1998; 28:751-755.
8. Kudo M, Chung H, Haji S, et al: Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with CLIP score. Hepatology 2004; 40:1396-1405.
9. Tateishi R, Yoshida H, Shiina S, et al: Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients. Gut 2005; 54:419-425.
10. Bruix J, Sherman M: Management of hepatocellular carcinoma. Hepato]ogy 2005; 42:1208-1236.
11. Hiraoka A, Kumagi T, Hirooka M, et al: Prognosis following transcatheter arterial embolization for 121 patients with unresectable hepatocellular carcinoma with and without a history of treatment World J Gastroenterol 2006; 12:2076-2080.
12. Matsui O, Kadoya M, Yoshikawa J, et al: Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate. Cancer Chemother Pharmacol 1993; 33:S84-88.
13. Mazzaferro V, Regalia E, Doci R, et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med 1996; 334:693-699.
14. Makuuchi M, Kokudo N: Clinical practice guidelines for hepatocellular carcinoma: the first evidemce based guidelines from Japan. World J Gastroenterol 2006; 12:828-829.
15. Ikai I, Arii S, Ichida T, et al: Report of the 16th follow-up survey of primary liver cancer. Hepatol res 2005; 32:163-172.
16. Takayasu K, Arii S, Ikai I, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 2006; 131:461-469.
17. Sakon M, Nagano H, Dono K, et al: - Combined intraarterial. 5-fluorouracil and subcutaneous interferon-alfa therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer 2002; 94:435-442.